Schedule 13G ownership disclosure

PDL BIOPHARMA INC

Security class unavailable · CUSIP: 69329Y104

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
16,336,458
Percent of class
10.1700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001445546-14-002946
Form type
SC 13G/A
Filer
FIRST TRUST PORTFOLIOS LP
CIK
CIK 1184765
Filed
Jun 10, 2014
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub